Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 7 · newest first

  1. Identification of PANoptosis-related lncRNAs in colorectal cancer: Bioinformatic and experimental insights into LMNTD2-AS1, ASMTL-AS1 and SNHG12Cancer Treatment and Research Communications · 2026
  2. Clinical and prognostic significance of CD4 expression in patients with de novo acute myeloid leukemia receiving intensive chemotherapyCancer Treatment and Research Communications · 2026
  3. Oncolytic virotherapy at the tumor microenvironment–CAR Therapy interface: Mechanisms, clinical translation, and future directionsCancer Treatment and Research Communications · 2026
  4. Clinical relative biological effectiveness of carbon-ion versus photon radiotherapy derived from tumor control probability models in locally advanced non-small cell lung cancerCancer Treatment and Research Communications · 2026
  5. Viral exploitation of p300/CBP at the virus-cancer interface: Chromatin regulation, oncogenesis, immune evasion, and therapeutic targetingCancer Treatment and Research Communications · 2026
  6. Racial and ethnic disparities in metabolic syndrome care among prostate cancer patients on androgen deprivation therapyCancer Treatment and Research Communications · 2026
  7. Nanosensitizer-based energy therapies for glioblastoma: A systematic review of a four-generation paradigm in evolving strategies (2020-2025)Cancer Treatment and Research Communications · 2026
  8. Validation of intratumoral necrosis as a prognostic marker in PDAC: Correlation with pathological findings and preoperative MDCT assessmentCancer Treatment and Research Communications · 2026
  9. LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinomaCancer Treatment and Research Communications · 2025
  10. Efficacy of fibrin sealants in preventing seroma formation following surgery for breast cancer: A systematic review and meta-analysisCancer Treatment and Research Communications · 2025
  11. Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A reviewCancer Treatment and Research Communications · 2025
  12. Efficacy evaluation of the 2017 protocol by the China Net Childhood Lymphoma in treating early T cell precursors-lymphoblastic lymphoma in pediatric patientsCancer Treatment and Research Communications · 2025
  13. Contemporary insights into head and neck cancers: Epidemiology, molecular biology, diagnosis, and therapeutic advancesCancer Treatment and Research Communications · 2025
  14. Comparative analysis of IHC, AMRS-PCR, and ddPCR for BRAF V600E mutation detection in papillary thyroid carcinomaCancer Treatment and Research Communications · 2025
  15. Hematologic malignancies and an overview of emerging therapies for hematologic malignancies: a systematic reviewCancer Treatment and Research Communications · 2025
  16. Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapyCancer Treatment and Research Communications · 2025
  17. Favourable long-term outcomes in selected HER2-Positive early breast cancer patients without pathological complete response after neoadjuvant chemotherapy and trastuzumab: A pre–T-DM1 era cohort studyCancer Treatment and Research Communications · 2025
  18. Advances in personalized cancer vaccine to nanotechnology innovationsCancer Treatment and Research Communications · 2025
  19. Research progress on the regulation of microRNAs by traditional Chinese medicine in the prevention and treatment of hepatocellular carcinomaCancer Treatment and Research Communications · 2025
  20. Trends in breast cancer incidence, age at diagnosis, and stage in Saudi Arabia, 2002–2022: a population-based studyCancer Treatment and Research Communications · 2025
  21. The role of nipple-areola complex tattooing in breast cancer psycho-physical rehabilitation: An updated reviewCancer Treatment and Research Communications · 2025
  22. The impact of metformin use on survival outcomes in colorectal cancer: A systematic review and meta-analysisCancer Treatment and Research Communications · 2025
  23. Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancerCancer Treatment and Research Communications · 2025
  24. Financial toxicity in breast cancer patients during radiotherapy – A German multicenter analysisCancer Treatment and Research Communications · 2025
  25. Pan-immune-inflammation value is associated with all-cause and cause-specific mortality among individuals with cancer survivors: a population-based longitudinal cohort studyCancer Treatment and Research Communications · 2025
  26. Intercostal nerves cryoanalgesia and open thoracotomy for major lung resection: evaluation of perioperative outcomes and medico-economic analysisCancer Treatment and Research Communications · 2025
  27. Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaCancer Treatment and Research Communications · 2025
  28. Pro-apoptotic effects of metformin and cisplatin in non-small cell Lung Cancer: Modulation of apoptosis-related genes and LncRNAsCancer Treatment and Research Communications · 2025
  29. The burden of bladder cancer in the MENA region: a 3-decade analysisCancer Treatment and Research Communications · 2025
  30. Clinical characteristics and prognostic outcomes in KRAS-mutant non-small cell lung cancer: A real-world study with or without COPD comorbidityCancer Treatment and Research Communications · 2025
  31. Tumor-microbe transkingdom interactions in cancers at body interfaces: mechanisms of neutrophil lifespan extension and functional reprogramming with therapeutic implicationsCancer Treatment and Research Communications · 2025
  32. The multifaceted role of midkine in gastrointestinal cancer: From biomarker to treatmentCancer Treatment and Research Communications · 2025
  33. Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasisCancer Treatment and Research Communications · 2025
  34. Impact of COVID-19 pandemic on treatment patterns for stage I Non-Small Cell Lung Cancer in the NetherlandsCancer Treatment and Research Communications · 2025
  35. Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort studyCancer Treatment and Research Communications · 2025
  36. Single-cell analysis of lung cancer metabolism and its clinical implicationsCancer Treatment and Research Communications · 2025
  37. Illuminating the spectrum of genomic sequencing approaches in the precision oncology era: A UK perspectiveCancer Treatment and Research Communications · 2025
  38. Profiles of blood biomarkers in lung cancerCancer Treatment and Research Communications · 2025
  39. Pleural Metastasis of Bone and Soft Tissue Sarcomas: A ReviewCancer Treatment and Research Communications · 2025
  40. Preliminary study of androgen receptor expression in oral lichen planus and oral squamous cell carcinoma: A comparative cross-sectional analysisCancer Treatment and Research Communications · 2025
  41. Exploring the application of PD-1/PD-L1 inhibitors for ovarian cancerCancer Treatment and Research Communications · 2025
  42. Serum ZFPL1 as a clinical biomarker for diagnosis, progression tracking, and treatment response in lung cancerCancer Treatment and Research Communications · 2025
  43. Comparative Assessment of Fistulectomy Alone Versus Fistulectomy with Immediate Sphincteroplasty in Anal Fistula TreatmentCancer Treatment and Research Communications · 2025
  44. Comprehensive pan-cancer analysis identified NSD2 as a potential prognostic and diagnostic biomarkerCancer Treatment and Research Communications · 2025
  45. Clinical and Molecular Characteristics of 42 Danish Patients with Metastatic ALK Fusion-Positive Lung Cancer Treated with First-Line Alectinib: A Nationwide StudyCancer Treatment and Research Communications · 2025
  46. Managing Squamous Cell Carcinoma of External Auditory Canal - A single institution experienceCancer Treatment and Research Communications · 2025
  47. Advancements in Nasopharyngeal Carcinoma Radiotherapy: Dosimetric Evaluation of Arc Therapy with Hippocampal SparingCancer Treatment and Research Communications · 2025
  48. Prognostic significance of lepidic component in invasive non-mucinous adenocarcinoma of the lungCancer Treatment and Research Communications · 2025
  49. CRISPR-mediated modulation of EGFR signaling in lung cancerCancer Treatment and Research Communications · 2025
  50. The effect of postoperative chemotherapy on blood glucose and prognosis in patients with advanced ovarian cancerCancer Treatment and Research Communications · 2025